How AI is helping to boost cancer screening
Briefly

Catching cancer early enhances treatment efficacy, with screenings like mammography and LDCT significantly reducing mortality rates. Notably, nearly 5 million deaths were prevented in the U.S. from 1975-2020 through these measures. However, challenges exist, especially for rarer cancers such as glioblastoma and disparities in access due to socioeconomic factors. The rising incidence of cancer among younger individuals and the lack of screening eligibility for them raises further concerns about prevention efforts. Cervical cancer, despite being highly preventable, continues to claim many lives, highlighting the need for improved access to screening.
We know from large-scale clinical trials that breast, colorectal, cervical and lung cancer screening works.
There's tremendous concern right now about cancer in the younger population being on the rise, but they're not eligible for screening.
Cervical cancer is the most preventable cancer, yet hundreds of thousands of women die every year from it.
Nearly 5 million cancer-related deaths were averted in the United States alone between 1975 and 2020 as a result of screening programmes.
Read at Nature
[
|
]